Provides information on a study to determine whether reducing cholesterol levels with HMGcoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase inhibitors or other antilipedemic interventions reduces risk for nonfatal and fatal stroke. Methodology used to conduct the study; Results of the study; Discussion on the results.